|
|
|
Volumn 17, Issue 12 Suppl 14, 2003, Pages 26-32
|
|
Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
MONOCLONAL ANTIBODY;
PACLITAXEL;
TRASTUZUMAB;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
FOLLOW UP;
HUMAN;
METASTASIS;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PATIENT SELECTION;
PHASE 2 CLINICAL TRIAL;
SALVAGE THERAPY;
SURVIVAL;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
PACLITAXEL;
PATIENT SELECTION;
SALVAGE THERAPY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
|
EID: 2142813963
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
